DEVICES AND METHODS FOR DETECTING PANCREATIC LIPASE

    公开(公告)号:US20240218421A1

    公开(公告)日:2024-07-04

    申请号:US18541764

    申请日:2023-12-15

    CPC classification number: C12Q1/44

    Abstract: Methods and devices for determining pancreatic lipase in an animal sample are provided. In one aspect, the device includes a basic buffer layer comprising one or more bile salts and calcium; an isolation layer comprising colipase; an indicator layer comprising a chromogenic substrate such as DGGR. The device may also include and a system for optically determining the amount of a development of a color change. The methods include the use of the device to detect pancreatic lipase in animal samples.

    CLINICAL DIAGNOSTIC AND PATIENT INFORMATION SYSTEMS AND METHODS

    公开(公告)号:US20230210473A1

    公开(公告)日:2023-07-06

    申请号:US18148163

    申请日:2022-12-29

    Abstract: A patient information system is described. A virtual representation of a patient is generated using a captured image of the patient. A graphical user interface is displayed on the display, the graphical user interface including a first screen portion configured to display the virtual representation of the patient and a second screen portion configured to display information. A selection of an area of interest is received on the virtual representation of the patient. Clinical and diagnostic information associated with the selected area of interest is received and displayed in the second screen portion of the graphical user interface. The graphical user interface also includes a timeline that displays events of interest. A selection of an event of interest causes the second screen portion of the graphical user interface to display clinical and diagnostic information associated with the selected event of interest.

    DETECTION OF SYMMETRICAL DIMETHYLARGININE

    公开(公告)号:US20230102277A1

    公开(公告)日:2023-03-30

    申请号:US17877410

    申请日:2022-07-29

    Abstract: The disclosure generally relates to the detection of symmetrical dimethylarginine (SDMA). More particularly, the disclosure relates to the detection of SDMA using a solid phase. The disclosure provides devices, reagents, kits and methods for detecting symmetrical dimethyl arginine (SDMA) in sample, such as a biological sample from an animal. The method includes detecting the presence or amount of SDMA in the sample by using an immunoassay format, such as a competitive immunoassay. The assay includes the use of antibodies to SDMA that are specific for SDMA and that have less affinity for other arginine derivatives.

Patent Agency Ranking